What is the approved wear duration of a Dexcom G7 continuous glucose monitoring sensor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dexcom G7 Sensor Wear Duration

The Dexcom G7 sensor is FDA-approved for 10 days of wear and must be replaced every 10 days. 1, 2

Official Wear Duration

  • The American Association of Clinical Endocrinologists and American Diabetes Association both confirm that the Dexcom G7 has a 10-day wear period 1
  • This 10-day duration is the manufacturer-specified and FDA-approved timeframe for the device 3

Clinical Performance Data

  • Accuracy studies demonstrate the G7 maintains performance throughout the full 10-day wear period, with mean absolute relative difference (MARD) of 8.2% for arm placement and 9.1% for abdomen placement across all 10 days 4
  • In pregnant women with diabetes, the G7 showed %20/20 agreement rates of 78.6% on day 1,96.3% on days 4-7, and 97.3% on day 10, demonstrating maintained or improved accuracy throughout wear 5

Real-World Wear Patterns

  • Despite the 10-day approval, real-world data shows most youth with type 1 diabetes wear sensors for less than the full duration, with median wear time of only 8.6 days 6
  • Only 39.9% of sensors were actually worn for the full 10 days or longer in a real-world cohort of 643 youth, while 24.8% were removed before 7 days 6
  • This shorter real-world wear means patients may require approximately 43 sensors per year rather than the standard 36 sensors typically provided to maintain continuous coverage 6

Critical Implementation Points

  • Never extend sensor wear beyond 10 days, as the device is not validated for longer use and accuracy deteriorates 1, 2
  • Insert a new sensor before removing the old one to avoid gaps in continuous glucose monitoring data 1, 2
  • The G7 is factory-calibrated and does not require fingerstick calibrations for treatment decisions 2

Extended Wear Research

  • An investigational 15.5-day version of the G7 has been studied and showed MARD of 8.0% with 87.7% of values within 15%/15 mg/dL of reference values, but this extended wear duration is not yet FDA-approved for clinical use 7

References

Guideline

Continuous Glucose Monitoring Sensor Replacement Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dexcom G6 Sensor Replacement Frequency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Accuracy of the 15.5-Day G7 iCGM in Adults with Diabetes.

Diabetes technology & therapeutics, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.